A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067

NCT01568034 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: BIA 9-1067
DRUG: BIA 9-1067
DRUG: BIA 9-1067
DRUG: Placebo
DRUG: Levodopa/Carbidopa
DRUG: Levodopa/Benzerazide

Sponsor

Bial - Portela C S.A.